DK442383A - Carbapenem-derivater og fremgangsmaade til fremstilling deraf - Google Patents

Carbapenem-derivater og fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK442383A
DK442383A DK442383A DK442383A DK442383A DK 442383 A DK442383 A DK 442383A DK 442383 A DK442383 A DK 442383A DK 442383 A DK442383 A DK 442383A DK 442383 A DK442383 A DK 442383A
Authority
DK
Denmark
Prior art keywords
procedures
preparing
carbapenem derivatives
carbapenem
derivatives
Prior art date
Application number
DK442383A
Other languages
Danish (da)
English (en)
Other versions
DK442383D0 (da
Inventor
Choung Un Kim
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK442383D0 publication Critical patent/DK442383D0/da
Publication of DK442383A publication Critical patent/DK442383A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
DK442383A 1982-09-28 1983-09-27 Carbapenem-derivater og fremgangsmaade til fremstilling deraf DK442383A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42575582A 1982-09-28 1982-09-28
US53001183A 1983-09-09 1983-09-09

Publications (2)

Publication Number Publication Date
DK442383D0 DK442383D0 (da) 1983-09-27
DK442383A true DK442383A (da) 1984-03-29

Family

ID=27026797

Family Applications (1)

Application Number Title Priority Date Filing Date
DK442383A DK442383A (da) 1982-09-28 1983-09-27 Carbapenem-derivater og fremgangsmaade til fremstilling deraf

Country Status (29)

Country Link
KR (1) KR890002228B1 (sv)
AR (1) AR241785A1 (sv)
AT (1) AT382621B (sv)
AU (1) AU575541B2 (sv)
CA (1) CA1269978A (sv)
CH (1) CH656130A5 (sv)
CS (1) CS247168B2 (sv)
DD (1) DD212255A5 (sv)
DE (1) DE3334937A1 (sv)
DK (1) DK442383A (sv)
ES (1) ES8503354A1 (sv)
FI (1) FI78094C (sv)
FR (1) FR2533568B1 (sv)
GB (1) GB2128187B (sv)
GR (1) GR78696B (sv)
HU (1) HU191066B (sv)
IE (1) IE55947B1 (sv)
IL (1) IL69824A (sv)
IT (1) IT1163944B (sv)
LU (1) LU85021A1 (sv)
NL (1) NL8303310A (sv)
NO (1) NO163284C (sv)
NZ (1) NZ205626A (sv)
OA (1) OA07548A (sv)
PT (1) PT77404B (sv)
SE (1) SE461734B (sv)
SU (1) SU1493108A3 (sv)
YU (1) YU43196B (sv)
ZW (1) ZW20783A1 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683296A (en) * 1983-03-07 1987-07-28 Bristol-Myers Company Carbapenem intermediates
CA1273012A (en) * 1984-07-02 1990-08-21 Burton G. Christensen 1-methylcarbapenems having an externally alkylated mono- of bicyclic 2-quarternary heteroarylalkylthio substituent
CA1273011A (en) * 1984-07-02 1990-08-21 Susan M. Schmitt Carbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkylthio substituent
US4729993A (en) * 1984-12-13 1988-03-08 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkyl substituent
US4725594A (en) * 1984-12-13 1988-02-16 Merck & Co., Inc. Carbapenems having an internally or externally alkylated mono- or bicyclic 2-quaternary heteroarylalxyl heteromethyl substituent
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4880922A (en) * 1985-11-22 1989-11-14 Bristol-Myers Company Carbapenems with quaternized heterothioalkylthio substitution at position 2
NZ219892A (en) * 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof
DK168047B1 (da) * 1987-12-07 1994-01-24 Lederle Japan Ltd (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaade til remstilling deraf, midler og praeparater indeholdende den krystallinske forbindelse samt dens anvendelse.
EP0876370A1 (en) 1996-01-12 1998-11-11 Takeda Chemical Industries, Ltd. Carbapenem compounds, their production and use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
PT73791B (en) * 1980-10-17 1983-10-14 Merck & Co Inc Process for preparing 2-carbamimidoyl-6-substituted-1- -carbadethiapen-2-em-3-carboxylic acids
EP0050927B1 (en) * 1980-10-25 1985-03-27 Beecham Group Plc The preparation of beta-lactam antibiotics
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
EP0074599A1 (en) * 1981-09-09 1983-03-23 Takeda Chemical Industries, Ltd. 5,6-cis-Carbapenem derivatives, their production and use

Also Published As

Publication number Publication date
CS247168B2 (en) 1986-12-18
IE55947B1 (en) 1991-02-27
KR840006249A (ko) 1984-11-22
FI78094B (fi) 1989-02-28
NO163284B (no) 1990-01-22
OA07548A (fr) 1985-03-31
NO833479L (no) 1984-03-29
GB2128187B (en) 1986-06-18
FR2533568B1 (fr) 1990-01-26
DK442383D0 (da) 1983-09-27
DE3334937A1 (de) 1984-04-05
AR241785A1 (es) 1992-12-30
IL69824A0 (en) 1983-12-30
DD212255A5 (de) 1984-08-08
CH656130A5 (de) 1986-06-13
YU43196B (en) 1989-04-30
PT77404B (en) 1986-06-26
NL8303310A (nl) 1984-04-16
ES525983A0 (es) 1985-02-16
ES8503354A1 (es) 1985-02-16
SU1493108A3 (ru) 1989-07-07
IL69824A (en) 1991-04-15
HU191066B (en) 1987-01-28
CA1269978A (en) 1990-06-05
IT8323022A0 (it) 1983-09-27
SE8305217L (sv) 1984-03-29
SE461734B (sv) 1990-03-19
LU85021A1 (fr) 1984-04-24
FR2533568A1 (fr) 1984-03-30
AT382621B (de) 1987-03-25
FI78094C (sv) 1989-06-12
ATA344983A (de) 1986-08-15
GB2128187A (en) 1984-04-26
FI833417A0 (fi) 1983-09-23
NZ205626A (en) 1986-12-05
GR78696B (sv) 1984-09-27
IT1163944B (it) 1987-04-08
GB8325744D0 (en) 1983-10-26
AU1934283A (en) 1984-04-05
PT77404A (en) 1983-10-01
IE832266L (en) 1984-03-28
NO163284C (no) 1990-05-02
DE3334937C2 (sv) 1991-05-02
ZW20783A1 (en) 1984-11-28
SE8305217D0 (sv) 1983-09-27
KR890002228B1 (ko) 1989-06-24
FI833417A (fi) 1984-03-29
YU190683A (en) 1985-10-31
AU575541B2 (en) 1988-08-04

Similar Documents

Publication Publication Date Title
DK493583A (da) Azolderivater og fremgangsmaade til fremstilling deraf
DK165321C (da) Oxiranderivater og fremgangsmaade til fremstilling deraf
DK224781A (da) Imidazo-rifamycin-derivater og fremgangsmaade til fremstilling deraf
DK302983D0 (da) Phenyl alpha-acyloxyacetamid-derivater og fremgangsmader til fremstilling deraf
DK99382A (da) Dichlorquinolinderivater og fremgangsmaade til fremstilling heraf
DK276683A (da) Carbapenemer og fremgangsmaade til fremstilling deraf
DK157683D0 (da) N-phosphonomethylglycinderivater og fremgangsmade til fremstilling og anvendelse deraf
DK572583A (da) Pyridinderivater og fremgangsmaade til fremstilling deraf
DK157083D0 (da) Carbapenem-derivater og fremgangsmade til fremstilling deraf
DK163917C (da) Gamma-substituerede beta-hydroxybutansyrederivater og fremgangsmaade til fremstilling heraf
DK442383D0 (da) Carbapenem-derivater og fremgangsmade til fremstilling deraf
DK199183D0 (da) Quinolinderivater og fremgangsmade til fremstilling deraf
DK621484D0 (da) Acylaminomitosaner og fremgangsmaade til fremstilling deraf
DK343684D0 (da) Phenyletherderivater og fremgangsmaade til fremstilling deraf
DK445784D0 (da) Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf
DK596784D0 (da) Phenylderivater og fremgangsmaade til fremstilling deraf
DK343183A (da) Ketoquinoliner og fremgangsmaade til fremstilling deraf
DK155983A (da) Carbapenem-derivater og fremgangsmaade til fremstilling deraf
DK135684A (da) 2-cyano-imidazopyridin-derivater og fremgangsmaade til fremstilling heraf
DK129983D0 (da) 2-beta-d-ribofuranosylselenazol-4-carboxamidforbindelser og fremgangsmader til fremstilling deraf
DK101683D0 (da) Phenylpiperazinderivater og fremgangsmade til fremstilling heraf
DK220982A (da) 7-oxoprostacyklinderivater og fremgangsmaade til fremstilling deraf
DK81192D0 (da) Substituerede ethandiimidamider og fremgangsmaade til fremstilling deraf
DK548380A (da) 7alfa-methoxycephalsporinderivater og fremgangsmaade til fremstilling deraf
DK90083D0 (da) Isoxazolopyrimidinderivater og fremgangsmade til fremstilling deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment